- Free from Publisher K Rossing, PK Christensen, BR Jensen, HH … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We performed a randomized double-blind crossover
study of 2 months treatment with candesartan cilexetil 8 mg once daily and
placebo in addition to previous antihypertensive treatment. We included 18 ... Cited by 181 - Related articles - BL Direct - All 5 versions
- ►oxfordjournals.org P Jacobsen, S Andersen, K Rossing, BV … - Nephrology Dialysis Transplantation, 2002 - ERA-EDTA Results. Addition of 300 mg Irbesartan to the patients' usual antihypertensive
therapy induced a mean reduction in albuminuria of 37% (95% CI 20–49,
P<0.001); from 1574 mg/24 h (95% CI 1162–2132) to 996 mg/24 h (95% CI ... Cited by 116 - Related articles - BL Direct - All 4 versions
P Jacobsen, S Andersen, K Rossing, BR … - Kidney international, 2003 - nature.com Albuminuria and hypertension are predictors of poor renal and cardiovascular
outcome in diabetic patients. We tested whether dual blockade of the
renin-angiotensin system (RAS) with both an angiotensin-converting enzyme ... Cited by 193 - Related articles - BL Direct - All 4 versions
- ►asnjournals.org P Jacobsen, S Andersen, BR Jensen, HH … - Journal of the American Society of Nephrology, 2003 - Am Soc Nephrol Albuminuria and hypertension are predictors of poor renal and cardiovascular
outcome in patients with diabetes (1,2 ). Antihypertensive treatment, especially
ACE-I, has been shown to reduce albuminuria, to diminish loss of kidney ... Cited by 152 - Related articles - BL Direct - All 7 versions
- Free from Publisher K Rossing, P Jacobsen, L Pietraszek, HH … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 20 patients (17 men and 3 women) with
type 2 diabetes along with hypertension and nephropathy were enrolled in this
double-blind, randomized, two-period, crossover trial of 8 weeks of ... Cited by 168 - Related articles - BL Direct - All 6 versions
R Agarwal - Kidney international, 2001 - nature.com Sixteen patients with proteinuric moderately advanced chronic renal failure
completed a two-period, crossover, randomized controlled trial. Each period was
one month with a two-week washout between periods. In one period, patients ... Cited by 120 - Related articles - BL Direct - All 4 versions
CE Mogensen, S Neldam, I Tikkanen, S Oren, … - British medical journal, 2000 - bmj.com The role of inhibition of the renin-angiotensin system in preventing
microvascular complications, particularly nephropathy, in patients with daibetes
has been clearly shown. 1-3 In many people with evidence of diabetic renal ... Cited by 767 - Related articles - BL Direct - All 15 versions
- ►oxfordjournals.org P Kincaid-Smith, K Fairley, D Packham - Nephrology Dialysis Transplantation, 2002 - ERA-EDTA Methods. This was an open randomized controlled crossover study conducted in a
private consultant practice in Melbourne. Sixty patients, aged 23–75, who had
chronic renal disease and stable proteinuria over 0.5 g in 24 h and were ... Cited by 86 - Related articles - BL Direct - All 6 versions
P Ferrari, HP Marti, M Pfister, FJ Frey - Journal of hypertension, 2002 - journals.lww.com Skip Navigation Links Home > January 2002 - Volume 20 - Issue 1 > Additive
antiproteinuric effect of combined ACE inhibition a... ... Ferrari, Paolo;
Marti, Hans-Peter; Pfister, Marc; Frey, Felix J. Cited by 120 - Related articles - BL Direct - All 4 versions
LM Ruilope, JC Aldigier, C Ponticelli, P Oddou … - Journal of hypertension, 2000 - journals.lww.com Page 1. Safety of the combination of valsartan and benazepril in patients with chronic
renal disease Luis M. Ruilopea, Jean C. Aldigierb, Claudio Ponticellic, ... Cited by 141 - Related articles - BL Direct - All 4 versions
